Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to compare the stone clearance rate treated with different drugs after ESWL in urinary calculus,These drugs are often used in urinary calculus,such as progesterone,tamsulosin,propantheline Bromide and nifedipine.In these study the investigators want to investigate different effect of these drugs use to treat urinary calculus after ESWL.


Clinical Trial Description

There is 4 groups in these investigation, group1 urinary calculus treated with ESWL only ,group2 urinary calculus treated with ESWL and tamsulosin,group3 urinary calculus treated with ESWL and progesterone,group4 urinary calculus treated with ESWL ,propantheline Bromide and nifedipine.We want to investigate which one is better or not in urinary calculus treated with ESWL . ;


Study Design

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01010048
Study type Interventional
Source Chongqing Medical University
Contact Yunfeng He, Doctor
Phone 86-23-89011121
Status Recruiting
Phase Phase 4
Start date October 2009
Completion date December 2010

See also
  Status Clinical Trial Phase
Completed NCT01539265 - A Dose-finding Study of Silodosin in Patients With Urinary Calculi Phase 2